Geographical patterns of in vitro susceptibilities to tigecycline and colistin among worldwide isolates of Acinetobacter baumannii, Escherichia coli and Klebsiella …

JL Wang, CC Lai, WC Ko, PR Hsueh - International journal of antimicrobial …, 2023 - Elsevier
This study aimed to investigate the geographical trends of minimum inhibitory
concentrations (MICs) for tigecycline and colistin in Acinetobacter baumannii, Escherichia …

[HTML][HTML] Investigation of colistin sensitivity via three different methods in Acinetobacter baumannii isolates with multiple antibiotic resistance

M Sınırtaş, H Akalın, S Gedikoğlu - International Journal of Infectious …, 2009 - Elsevier
BACKGROUND: In recent years there has been an increase in life-threatening infections
caused by Acinetobacter baumannii with multiple antibiotic resistance, which has lead to the …

Rapid dissemination of colistin and carbapenem resistant Acinetobacter baumannii in Central Greece: mechanisms of resistance, molecular identification and …

O Oikonomou, S Sarrou, CC Papagiannitsis… - BMC infectious …, 2015 - Springer
Background Colistin-resistant/carbapenem-resistant Acinetobacter baumannii is a
significant challenge for antibiotic treatment and infection control policies. Since 2012, in …

Misidentification of ampicillin–sulbactam heteroresistance in Acinetobacter baumannii strains from ICU patients

V Savini, C Catavitello, M Talia, F Febbo… - Journal of …, 2009 - journalofinfection.com
Acinetobacter baumannii is a ubiquitous organism, that commonly behaves as an
opportunistic pathogen causing nosocomial outbreaks among burn or intensive care …

High rate of colistin dependence in Acinetobacter baumannii

YK Hong, JY Lee, YM Wi, KS Ko - Journal of Antimicrobial …, 2016 - academic.oup.com
Sir, Colistin is currently considered the last treatment option for MDR Acinetobacter
infections. Although the current resistance rates to colistin are relatively low, they are …

Antimicrobial susceptibility among gram-negative isolates collected from intensive care units in North America, Europe, the Asia-Pacific Rim, Latin America, the Middle …

X Bertrand, MJ Dowzicky - Clinical therapeutics, 2012 - Elsevier
BACKGROUND: The Tigecycline Evaluation and Surveillance Trial is an antimicrobial
susceptibility surveillance program that collects gram-positive and gram-negative organisms …

Emergence of mcr-and fosA3-mediated colistin and fosfomycin resistance among carbapenem-resistant Acinetobacter baumannii in Iraq

SM Kareem - Meta Gene, 2020 - Elsevier
Introduction Acinetobacter baumannii infections have spread in healthcare and community
settings with extensive drug-resistance in various locations. Considering importance of …

[HTML][HTML] Global update on the in vitro activity of tigecycline and comparators against isolates of Acinetobacter baumannii and rates of resistant phenotypes (2016–2018 …

H Seifert, J Blondeau, K Lucassen, EA Utt - Journal of Global Antimicrobial …, 2022 - Elsevier
Objectives This study presents 2016–2018 in vitro antimicrobial activity data and rates of
resistant phenotypes for clinical isolates of Acinetobacter baumannii from Africa/Middle East …

Antimicrobial resistance profiles and genetic elements involved in carbapenem resistance in Acinetobacter baumannii isolates from a referral hospital in Southern Iran

N Alaei, M Aziemzadeh, A Bahador - Journal of Global Antimicrobial …, 2016 - Elsevier
In this study, antimicrobial resistance patterns, carbapenemase production, carbapenem-
hydrolysing class D OXA-type β-lactamase (CHDL)-encoding genes and ISAba insertion …

Changes in MIC within a global collection of Acinetobacter baumannii collected as part of the Tigecycline Evaluation and Surveillance Trial, 2004 to 2009

R Morfin-Otero, MJ Dowzicky - Clinical therapeutics, 2012 - Elsevier
BACKGROUND: The Tigecycline Evaluation and Surveillance Trial (TEST) began in 2004 to
monitor global antimicrobial susceptibility to tigecycline and a range of comparator …